Parkinson’s UK supports active living with enhanced Physical Activity Grants in 2024

Parkinson’s UK is offering its popular Physical Activity Grants programme to help more people living with Parkinson’s get active in 2024.

LimmaTech secures funding for vaccine technology development

Share this article LimmaTech will utilise the additional funds to expedite the preclinical and clinical development of its vaccine candidate pipeline. Credit: BaLL LunLa /

February 2, 2024

Lilly gets June adcomm for Alzheimer’s drug donanemab, following earlier delay

Eli Lilly will face questions from a panel of Alzheimer’s experts on June 10, setting up an approval decision for donanemab after a surprise delay

May 8, 2024

Heat shock protein protects bacteria from plasma treatment

A heat shock protein protects the cells against protein clumping. It degrades, however, over longer treatment periods.

November 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.